HHS, Inflammatix To Develop Test Distinguishing Bacterial, Viral Infections

By Kelly Lienhard / November 15, 2019 at 6:09 PM
HHS, as part of its bid to combat antimicrobial resistance, is partnering with Inflammatix Inc. to develop a diagnostic test that reads genetic expression patterns in the immune system to determine whether an infection is bacterial or viral. The department hopes the new diagnostic technique will also determine the severity of an infection within minutes. The technology, known as host-response testing, will be developed under a $6 million, 14-month contract between the Biomedical Advanced Research and Development Authority ( BARDA...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.